success
          fail
          
            
          
          
            
          
          
        	
	
      
      
	
	
      
    
    
      
	
	  
	    
	  
	  
	    
	      
		
		
		  Feb
		  OCT
		  Dec
		
		
		
		  
		  21
		  
		
		
		
		  2001
		  2002
		  2004
		
	      
	    
	  
	
	
	  
	    	    
	      	      26 captures
	      17 Apr 2000 - 19 Jan 2009
	      
	  
	  
	    
	      
		
	      
	    
	  
	
      
    
    
       About this capture
    
  
    
            COLLECTED BY
    
            
			
		Organization: Alexa Crawls
		
	  
	  Starting in 1996, Alexa Internet has been donating their crawl data to the Internet Archive.  Flowing in every day, these data are added to the Wayback Machine after an embargo period.
	
	      
      
			
		Collection: alexa_dn
		
	  
	  this data is currently not publicly accessible.
	
	      
    
    TIMESTAMPS
    
      
      
    
  

FDA            
Enforcement Report
The FDA Enforcement Report is published weekly by the Food and
Drug Administration,
U.S. Public Health Service, Department of Health and Human
Services.  It contains information
on actions  taken in connection with agency regulatory
activities.



June 16, 1999                                        99-24

RECALLS AND FIELD CORRECTIONS:  FOODS -- CLASS II
________
PRODUCT
Parkside Candy, "Deluxe Assortment" boxed chocolate assortments, 
sold in 8 ounce, 16 ounce and 32 ounce boxes.  Recall #F-448-9.
CODE
None.
MANUFACTURER
Parkside Candy, Company, Buffalo, New York.
RECALLED BY
Manufacturer, by visit on April 8, 1999.  Completed recall 
resulted from sample analysis and follow-up by the New York State 
Department of Agriculture and Markets.
DISTRIBUTION
New York.
QUANTITY
Undetermined.
REASON
Product lists "nut meats" as an ingredient without listing the 
individual nuts.  In addition, the product contains peanut 
residue.

RECALLS AND FIELD CORRECTIONS:  FOODS -- CLASS III
________
PRODUCT
St. John's Wort Capsules, 250 mg, under the Aurora Healthcare and 
Nature's Blend labels, 60 capsules per bottle.
Recall #F-441-9.
CODE
A8-87 and W7-81.
MANUFACTURER
National Vitamin Company, Inc., Porterville, California.
RECALLED BY
Manufacturer, by letter on March 12, 1999, followed by visit.  
Firm-initiated recall ongoing.
DISTRIBUTION
Nationwide and international.
QUANTITY
23,679 bottles were distributed.
REASON
Products contain less hypericin than the amount declared on the 
label.  Lot A8-87 contains <36% and lot W7-81 contains 12% of the amount hypericin declared. _________ PRODUCT
Minute Maid Premium 100% Orange Juice from concentrate in 8.45 
ounce (250 ml) aseptic drink box containers.
Recall #F-446-9.
CODE
Expiration Dates JUL0799 and JUL0899.
MANUFACTURER
Whitlock Packaging Corporation, Fort Gibson, Oklahoma.
RECALLED BY
The Minute Maid Company, Houston, Texas, by visit on April 22, 
1999.  Firm-initiated recall complete.
DISTRIBUTION
California.
QUANTITY
3,018 cases of 27 cartons each were distributed.
REASON
Product may be contaminated with mold.
________
PRODUCT
Big K (Kroger brand) Koolers Sweet Tea, in 11.5 fluid ounce cans. 
 Recall #F-447-9.
CODE
Sell by 15 SEP 99 CVSA.
MANUFACTURER
Springdale Ice Cream & Beverage, Cincinnati, Ohio.
RECALLED BY
The Kroger Company, Cincinnati, Ohio, by electronic mail on April 
21, 1999, followed by telephone and fax.  Completed recall 
resulted from sample analysis and follow-up by the Indiana State 
Department of Health, Food Protection Program (ISDH).
DISTRIBUTION
Georgia, Alabama, South Carolina, Indiana, Kentucky, Ohio, West 
Virginia, Illinois, Missouri, Michigan, Tennessee, Virginia, 
North Carolina.
QUANTITY
8,697 cases (104,364) cans were distributed.
REASON
Product may be contaminated with yeast.

RECALLS AND FIELD CORRECTIONS:  DRUGS -- 
CLASS II
_________
PRODUCT
Liothyronine Sodium, USP, bulk powder in 1 and 5 gram containers, 
Rx for the treatment of hypothyroidism.
Recall #D-243-9.
CODE
9802163, 971257, 9808168, and 9802133.
MANUFACTURER
Gallipot, Inc., St. Paul, Minnesota.
RECALLED BY
Manufacturer, by telephone on or about January 28, 1999.  Firm-
initiated recall complete.
DISTRIBUTION
Nationwide.
QUANTITY
2 5-g containers and 10 1-gallon containers were distributed.
REASON
Product is Mislabeled - Actually contains Levothyroxine Sodium.
________
PRODUCT
Bromocriptine Mesylate, USP, Rx used to reduce tumor size prior 
to performing surgeries:  a) Bromocriptine Mesylate Tablets 2.5 
mg, in 30 and 100 count bottles, under the Rosemont and Mylan 
labels; b) Bromocriptine Mesylate Capsules 5 mg, in 30 and 100 
count bottles under the Rosemont label. Recall #D-245/246-9.
CODE
All lots within expiration date.
MANUFACTURER
Lek Pharmaceutical and Chemical Company, Ljubijana, Slovenia.
RECALLED BY
Lek, USA Englewood Cliffs, New Jersey, by telephone and fax on 
March 9, 1999, and by letter dated April 1, 1999.  Firm-initiated 
recall ongoing.
DISTRIBUTION
Colorado.
QUANTITY
a) 6,678,000 bottles; b) 881,000 bottles were distributed.
REASON
Lack of assurance of bioequivalence.
________
PRODUCT
Levothyroxine Sodium Tablets, Rx in bottles of 100 and 1000, used 
as a replacement or supplemental therapy in patients with 
hypothyroidism and as a pituitary TSH suppressant in the 
treatment or prevention of various types of euthyroid goiters:  
a) 25 mcg (0.025mg); b) .50 mg (0.05mg);
c) 150 mcg (.15mg); d) 300 mcg (.3mg).  Recall #D-256/259-9.
CODE
a) Levothyroxine Sodium 0.025mg Rx Tablets, lot #'s:
004097A, exp. 02/99 (NDC #0254-3911-28)
004097B, exp. 02/99 (NDC #0254-3911-28)
004097C, exp. 02/99 (NDC #0603-4192-32)
047117D, exp. 05/99 (NDC #0603-4192-32)
047117E, exp. 05/99 (NDC #0254-3911-38)
047117G, exp. 05/99 (NDC #0677-1648-01)
047117H, exp. 05/99 (NDC #0677-1648-10)
032127A, exp. 05/99 (NDC #0254-3911-28)
032127B, exp. 05/99 (NDC #0254-3911-38)
032127C, exp. 05/99 (NDC #0254-4192-21)
032127D, exp. 05/99 (NDC #0603-4192-32)
033127B, exp. 05/99 (NDC #0603-4192-21)
033127C, exp. 05/99 (NDC #0603-4192-32)
033127D, exp. 05/99 (NDC #0254-3911-28)
033127E, exp. 05/99 (NDC #0254-3911-38)
b) Levothyroxine Sodium 0.05mg Rx Tablets, lot #'s:
005097A, exp. 02/99 (NDC #0254-3912-38)
005097F, exp. 02/99 (NDC #0254-3912-38)
006097A, exp. 02/99 (NDC #0603-4193-32)
004127A, exp. 05/99 (NDC #0603-4193-21)
004127B, exp. 05/99 (NDC #0254-3912-28)
004127C, exp. 05/99 (NDC #0603-4193-32)
c) Levothyroxine Sodium 0.150mg Tablets, lot #'s:
044087A, exp. 07/99 (NDC #0603-4196-21)
044087B, exp. 07/99 (NDC #0254-3915-28)
044087C, exp. 07/99 (NDC #0677-0992-01)
044087D, exp. 07/99 (NDC #0254-3915-38)
044087E, exp. 07/99 (NDC #0603-4196-32)
d) Levothyroxine Sodium 0.3mg Rx Tablets, lot #'s:
017047C, exp. 03/99 (NDC #0254-3917-28)
017047D, exp. 03/99 (NDC #0254-3917-28)
017047F, exp. 03/99 (NDC #0254-3917-28)
017047G, exp. 03/99 (NDC #0603-4198-21)
017047B, exp. 03/99 (NDC #0603-3917-38).
MANUFACTURER
Vintage Pharmaceuticals, Inc., Charlotte, North Carolina.
RECALLED BY
Manufacturer, by letter dated November 11, 1998.  Firm-initiated 
recall ongoing.
DISTRIBUTION
Alabama.
QUANTITY
4800 bottles of Levothyroxine Sodium 0.025mg, lot #004097A.
6077 bottles of Levothyroxine Sodium 0.025mg, lot #004097B.
954 bottles of Levothyroxine Sodium 0.025mg, lot #004097C.
532 bottles of Levothyroxine Sodium 0.025mg, lot #047117D.
1369 bottles of Levothyroxine Sodium 0.025mg, lot #047117E.
1421 bottles of Levothyroxine Sodium 0.025mg, lot #047117G.
838 bottles of Levothyroxine Sodium 0.025mg, lot #047117H.
4192 bottles of Levothyroxine Sodium 0.025mg, lot #032127A.
1208 bottles of Levothyroxine Sodium 0.025mg, lot #032127B.
2772 bottles of Levothyroxine Sodium 0.025mg, lot #032127C.
984 bottles of Levothyroxine Sodium 0.025mg, lot #032127D.
2592 bottles of Levothyroxine Sodium 0.025mg, lot #033127B.
1800 bottles of Levothyroxine Sodium 0.025mg, lot #033127C.
2527 bottles of Levothyroxine Sodium 0.025mg, lot #033127D.
600 bottles of Levothyroxine Sodium 0.025mg, lot #033127E.
1179 bottles of Levothyroxine Sodium 0.05mg, lot #005097A.
804 bottles of Levothyroxine Sodium 0.05mg, lot #005097F.
3000 bottles of Levothyroxine Sodium 0.05mg, lot #006097A.
3192 bottles of Levothyroxine Sodium 0.05mg, lot #004127A.
9720 bottles of Levothyroxine Sodium 0.05mg, lot #004127B.
1074 bottles of Levothyroxine Sodium 0.05mg, lot #004127C.
652 bottles of Levothyroxine Sodium 0.3mg, lot #017047C.
1792 bottles of Levothyroxine Sodium 0.3mg, lot #017047D.
1440 bottles of Levothyroxine Sodium 0.3mg, lot #017047F.
1200 bottles of Levothyroxine Sodium 0.3mg, lot #017047G.
924 bottles of Levothyroxine Sodium 0.3mg, lot #017047B. 
1407 bottles of Levothyroxine Sodium 0.150mg lot #044087A.
1784 bottles of Levothyroxine Sodium 0.150mg lot #044087B.
1195 bottles of Levothyroxine Sodium 0.150mg lot #044087C.
829 bottles of Levothyroxine Sodium 0.150mg lot #044087D.
589 bottles of Levothyroxine Sodium 0.150mg lot #044087E.
REASON
Lack of assurance of potency through expiration date.

RECALLS AND FIELD CORRECTIONS:  DRUGS -- CLASS III
________
PRODUCT
Lycall Cold Sore Ointment (Lysine/Camphor/Menthol), in 8 gram 
jars.  Recall #D-242-9.
CODE
Lot #1541 EXP 23/01.
MANUFACTURER
Caleb Laboratories, Inc., Minneapolis, Minnesota.
RECALLED BY
Manufacturer, by telephone beginning on April 28, 1999, and by 
letter faxed on April 28, 1999.  Firm-initiated recall ongoing.
DISTRIBUTION
Minnesota, Wisconsin, North Dakota, Colorado.
QUANTITY
924 jars were distributed.
REASON
Lysine subpotency.
________
PRODUCT
Rugby brand Calcium Carbonate Tablets, 10 gr (648 mg), in 1,000 
tablet containers.  Recall #D-244-9.
CODE
Lot #1795-8911 EXP 11/02.
MANUFACTURER
Tischon Corporation, Salisbury, Maryland.
RECALLED BY
Tishcon Corporation, Westbury, New York, by fax and certified 
mail on April 12, 1999.  Firm-initiated recall ongoing.
DISTRIBUTION
Georgia.
QUANTITY
1,005 bottles were distributed.
REASON
Tablet mix-up - Bottles contain brewer's yeast tablets (light 
brown).
________
PRODUCT
Acyclovir Tablets or Capsules, Rx used as an anti-viral 
medication for Herpes Simplex I:
a) 200 mg, in 100, 500 and 1,000 capsule bottles
b) 400 mg, Rx in 100, 500, and 1,000 tablet bottles
c) 800 mg, Rx in 100, 500, and 1,000 tablet bottles
Labels and NDC Numbers --
Schein Pharmaceuticals  
0365-2692-01    100 capsules/200 mg
0364-2689-01    100 tablets/400 mg
0364-2689-05    500 tablets/400 mg
0364-2689-01    100 tablets/800 mg
Mylan Pharmaceutical Inc.
0378-1464-01    100 tablets/400 mg
0378-1468-01    100 tablets/800 mg
Par Pharmaceutical
49884-460-05    200 mg   500 capsules
49884-460-01             100 capsules
49884-460-10             1000 capsules
49884-487-01    400 mg   100 tablets
49884-487-05             500 tablets
49884-487-10             1000 tablets
49884-474-01    800 mg   100 tablets
49884-474-05             500 tablets
49884-474-10             1000 tablets
Cimetidine Tablets, used as a stomach acid reducer for patients 
with stomach ulcers 
d) 200 mg, Rx and OTC, in 6,10, 12,18, 30, 50, 60, 90, and 100 
count units
e) 300 mg, Rx in 100, 500, and 1,000 count bottles
f) 400 mg, Rx in 60, 100, 500, and 1,000 count bottles
g) 800 mg, Rx in 30, 100, and 250 count bottles.
Labels and NDC Numbers--
Cimetidine 200 mg OTC
Firm Name                NDC#       Packaged Size 
Eckerd Drug Company   19458-957-61   6 tablet blister 
                      19458-957-62  18 tablet blister
                      19458-957-63  30 tablet blister
                      19458-957-64  60 tablet blister
Albertson's           41163-229-08  30 tablet blister
Equate                50606-229-08  30 tablet blister
Packaged by           50606-229-15  60 tablet blister
BI-MART                             12 tablet blister
                                    30 tablet blister
Western Family Foods, Inc.          12 tablet blister 
                                    30 tablet blister
Kaiser Permanente     00179-1308-30 30 tablet blister
                      00179-1308-90 90 tablet blister
Pharmacist Formula                  18 tablet blister
Marketed by:          (special 30 tablet blister for above)
Leiner Health Products, Inc.   30 tablet blister
                               50 tablet blister
VONS                 58828-229-08  30 tablet blister
Safeway Inc.         21130-229-08  30 tablet blister
Bulk shipping label
LEK Pharmaceutical and Chemical Co., d.d.
Ljubljana, Slovenia      60x6 coated tablet blister
                         60x6 tablets acid reducer
                         60x10 tablets acid reducer
                         60x10 coated tablets
Cimetidine 200 mg, RX 
Rosemont     0832-0101-00  100 tablet bottles  
Brightstone  62939-2111-1  100 tablet bottles
Schein       364-2591-01 100 tablet bottles
             0364-2591-01  100 tablet bottles
Martec       52555-708-01  100 tablet bottles
Qualitest    0603-2890-21  100 tablet bottles
URL          0677-1527-01  100 tablet bottles
Cimetidine 300 mg
Rosemont        0102-00  100 tablet bottles
                0832-0102-50  500 tablet bottles
                0832-0102-10 1000 tablet bottles
Brightstone     62939-2121-1  100 tablet bottles
Schein          0364-2592-01  100 tablet bottles
                0364-2592-05  500 tablet bottles
Martec          52555-709-01  100 tablet bottles
Apothecon       59772-0229-5  500 tablet bottles
Qualitest       0603-2891-28  500 tablet bottles
URL             0677-1528-01  100 tablet bottles
MOVA            55370-866-07  100 tablet bottles
Cimetidine 400 mg
Rosemont          0832-0103-06   60 tablet bottles
                  0832-0103-00  100 tablet bottles
                  0832-0103-50  500 tablet bottles
                  0832-0103-10 1000 tablet bottles
Brightstone       62939-2131-1  100 tablet bottles
Martec            52555-710-01  100 tablet bottles
Schein            0364-2593-01  100 tablet bottles
                  0364-2593-05  500 tablet bottles
URL               0677-1529-01  100 tablet bottles
                  0677-1529-05  500 tablet bottles
Novapharm         55953-436-40  100 tablet bottles
                  55953-436-70  500 tablet bottles
                  55953-436-80 1000 tablet bottles
Apothecon         59772-0230-3  100 tablet bottles
                  59772-0230-7  500 tablet bottles
Qualitest         0603-2892-28  500 tablet bottles
Cimetidine 800 mg
Rosemont        0832-0104-03   30 tablet bottles
                0832-0104-00  100 tablet bottles
                0832-0104-25  250 tablet bottles
Martec          52555-711-01  100 tablet bottles
Novapharm       55953-516-40  100 tablet bottles
Schein          0364-2594-01  100 tablet bottles
                0364-2594-01  
Brightstone     62939-2141-1  100 tablet bottles
Qualitest       0603-2893-21  100 tablet bottles
Apothecon       59772-0231-3  100 tablet bottles
                59772-0231-4  250 tablet bottles.
Recall #D-247/253-9.
CODE
All lots within expiration date.
MANUFACTURER
LEK Pharmaceutical and Chemical Company, Ljubljana, Slovenia.
RECALLED BY
LEK, USA Englewood Cliffs, New Jersey, by telephone or fax March 
7 or 9, 1999, and by letter dated April 1 or 15, 1999.  Firm-
initiated recall ongoing.
DISTRIBUTION
New Jersey, New York, West Virginia.
QUANTITY
Acyclovir Tablets --    37,464 bottles (Par)
                       430,284 bottles (Schein)
                       740,000 bottles (Mylan)
Acyclovir Capsules --   22,110 bottles (Par)
                        320,378 bottles (Schein)
Cimetidine Tablets -- 
200 mg OTC 11,026 blisters
200 mg RX   34,866 bottles 
400 mg      307,813 bottles
800 mg      130,139 bottles were distributed.
REASON
Lack of assurance of bioequivalence.
________
PRODUCT
Astra 4% Citanest Forte with Epinephrine 1:200,000 (Prilocaine 
and Epinephrine Injection, USP), in 1.8 mL cartons, indicated for 
the production of local anesthesia in dentistry.  NDC #0186-0540-
14.  Recall #D-255-9.
CODE
Lot No.             Expiration Date 
0540801072          Jul-99
0540801075          Jul-99
0540802017          Aug-99
0540803036          Sep-99
0540803044          Sep-99
0540803053          Sep-99
0540803072          Sep-99
0540803090          Sep-99
0540804018          Oct-99
0540804023          Oct-99
0540804037          Oct-99
0540804049          Oct-99
0540804054          Oct-99
0540804103          Oct-99
0540804107          Oct-99
0540805001          Nov-99
MANUFACTURER
Astra Pharmaceuticals, L.P., Westborough, Massachusetts.
RECALLED BY
Manufacturer, by letter on May 28, 1999.  Firm-initiated recall 
ongoing.
DISTRIBUTION
Nationwide.
QUANTITY
56,252 units were distributed
REASON
Epinephrine subpotency (stability).

RECALLS AND FIELD CORRECTIONS:  BIOLOGICS -- CLASS II
________
PRODUCT
a) Whole Blood; b) Red Blood Cells; c) Red Blood Cells, 
Leukocytes Removed; d) Fresh Frozen Plasma; e) Recovered Plasma. 
 Recall #B-840/844-9.
CODE
Contact FDA, Center for Biologics Evaluation and Research, Office 
of Compliance (301) 827-6220 for individual unit numbers 
recalled.
MANUFACTURER
United Blood Services, Phoenix, Arizona.
RECALLED BY
Blood Systems, Inc., Scottsdale, Arizona, by fax or telephone on 
January 29, 1999, and by letters dated February 25, 1999.  Firm-
initiated recall complete.
DISTRIBUTION
Arizona, Tennessee, Georgia, and Switzerland.
QUANTITY
a) 2 units; b) 40 units; c) 1 unit; d) 12 units; e) 17 units were 
distributed.
REASON
Blood products were collected in a manner that compromises the 
sterility of the units.
________
PRODUCT
Platelets.  Recall #B-845-9.
CODE
Unit #19GJ45444.
MANUFACTURER
American Red Cross Blood Services, Nashville, Tennessee.
RECALLED BY
Manufacturer, by telephone on November 2, 1998, followed by 
letter dated November 3, 1998.  Firm-initiated recall complete.
DISTRIBUTION
Kentucky.
QUANTITY
1 unit was distributed.
REASON
Blood product was collected from a donor taking the drug 
Methotrexate.
________
PRODUCT
National Biomedical Computer System, Versions 1.1 to 1.3.2.
Recall #B-861-9.
CODE
Software versions 1.1 to 1.3.2.
MANUFACTURER
American Red Cross Blood Services, Arlington, Virginia.
RECALLED BY
Manufacturer, by letter dated January 6, 1999.  Firm-initiated 
recall complete.
DISTRIBUTION
Nationwide.
QUANTITY
38 systems were distributed.
REASON
Y2K defect in the computer software incorrectly calculates the 
end date of a temporary deferral to be 1900 instead of 2000, and 
removes the deferral from the database.  
________
PRODUCT
a) Red Blood Cells; b) Platelets; c) Fresh Frozen Plasma.
Recall #B-864/866-9.
CODE
Unit #24KL33003.
MANUFACTURER
American Red Cross Blood Services, Louisville, Kentucky.
RECALLED BY
Manufacturer, by letters dated December 9 and 10, 1998.  Firm-
initiated recall complete.
DISTRIBUTION
Kentucky.
QUANTITY
1 unit of each component was distributed.
REASON
Blood products were collected from a donor who previously tested 
positive for hepatitis.
________
PRODUCT
Platelets, Pheresis.  Recall #B-867-9.
CODE
Unit #19GL23665.
MANUFACTURER
American Red Cross Blood Services, Nashville, Tennessee.
RECALLED BY
Manufacturer, by telephone on January 4, 1999.  Firm-initiated 
recall complete.
DISTRIBUTION
Tennessee.
QUANTITY
1 unit was distributed.
REASON
Blood product had an unacceptable platelet yield.
________
PRODUCT
Red Blood Cells.  Recall #B-868-9.
CODE
Unit numbers:  19GF56903 and 19GF53660.
MANUFACTURER
American Red Cross Blood Services, Nashville, Tennessee.
RECALLED BY
Manufacturer, by letters dated November 23, 1998, and December 
28, 1998.  Firm-initiated recall complete.
DISTRIBUTION
Tennessee.
QUANTITY
2 units were distributed.
REASON
Blood products were collected from a donor who traveled to an 
area considered endemic for malaria.

RECALLS AND FIELD CORRECTIONS:  BIOLOGICS -- CLASS III
________
PRODUCT
Various Custom Allergenic extract Mixtures and Stock Extracts.  
Recall #B-863-9.
CODE
A total of 637 different lot numbers are subject to recall.
MANUFACTURER
Allergy Laboratories of Ohio, Inc., Columbus, Ohio.
RECALLED BY
Manufacturer, by letter on either February 17, 1999, March 5, 8, 
10, 11, 12, 15, 16, 17, or 18, 1999.  Firm-initiated recall 
ongoing.
DISTRIBUTION
Nationwide.
QUANTITY
1,521 vials were distributed.
REASON
Allergenic extracts were labeled with extended expiration dates.
________
PRODUCT
Fresh Frozen Plasma, Pheresis.  Recall #B-881-9.
CODE
Unit #19GL15526.
MANUFACTURER
American Red Cross Blood Services, Nashville, Tennessee.
RECALLED BY
Manufacturer, by telephone on October 27, 1997.  Firm-initiated 
recall complete.
DISTRIBUTION
Tennessee.
QUANTITY
1 unit was distributed.
REASON
Blood product may not have been frozen within the acceptable time 
limit.

RECALLS AND FIELD CORRECTIONS:  DEVICES -- 
CLASS I
________
PRODUCT
Get Smart Be Prepared, 207 piece Emergency First Aid Kit.
Recall #Z-954-9.
CODE
Not coded -- Only the kits with a red cross on the label are 
subject to recall.
MANUFACTURER
Total Resources International, Inc., Walnut, California.
RECALLED BY
Manufacturer, by letter dated April 22, 1999.  Firm-initiated 
recall ongoing.
DISTRIBUTION
Pennsylvania, Maryland, Mississippi, Missouri, Arkansas, 
Louisiana, Texas.
QUANTITY
5,000 first aid kits were distributed.
REASON
The Povidone Iodine pads in the kits are contaminated with 
microorganisms such as Pseudomonas putida, Salmonella spp., Poly 
D, and Aeromonas sorbia.

RECALLS AND FIELD CORRECTOINS:  DEVICES -- CLASS II
________
PRODUCT
IiRAD DR1000C Digital Chest System, general purpose x-ray device. 
 Recall #Z-949-9.
CODE
Model IiRAD DR1000C.
MANUFACTURER
Fischer Imaging Corporation, Denver, Colorado.
RECALLED BY
Manufacturer.  FDA approved the firm's corrective action plan 
June 1999.  Firm-initiated field correction ongoing.
DISTRIBUTION
Nationwide.
QUANTITY
2 units were distributed.
REASON
The units are defective under 21 CFR 1003.2 in that they do not 
assure certification to field sizing specifications are met 
because the system intermittently opens wide open in the vertical 
direction when the exposure button is depressed.  This can result 
in the patient receiving excess exposure where no useful 
diagnostic imaging can occur.
________
PRODUCT
CryoValve Allograft (heart valve), Model PV00.  
Recall #Z-980-9.
CODE
Serial number 6553109.
MANUFACTURER
CryoLife, Inc., Kennesaw, Georgia.
RECALLED BY
Manufacturer, by letter on March 26, 1999.  Firm-initiated recall 
complete.
DISTRIBUTION
Utah.
QUANTITY
1 unit was distributed and subsequently destroyed.
REASON
The donor�s final autopsy report, which included a histological 
exam of the donor�s brain, revealed evidence of viral 
encephalitis.
________
PRODUCT
CryoValve Allograft (heart valve), Model PVOO.
Recall #Z-981-9.
CODE
Serial #6406157.
MANUFACTURER
CryoLife, Inc., Kennesaw, Georgia.
RECALLED BY
Manufacturer, by letter on March 29, 1999.  Firm-initiated recall 
complete.
DISTRIBUTION
Michigan.
QUANTITY
1 unit was distributed.
REASON
The donor�s final autopsy report revealed undiagnosed   Sarcoma 
(Fibrosarcoma) of the right leg.
________
PRODUCT
CryoValve Allograft (heart valve):
a) Model No. AV40, Serial No. 6285082;
b) Model No. AV05, Serial No. 6314988.  Recall #Z-982/983-9.
CODE
a) Serial No. 6285082; b) Serial No. 6314988.
MANUFACTURER
CryoLife, Inc., Kennesaw, Georgia.
RECALLED BY
Manufacturer, by letter on April 1, 1999.  Firm-initiated recall 
complete.
DISTRIBUTION
a) Maryland; b) Texas.
QUANTITY
1 unit of each component was distributed.
REASON
The donors do not meet current guidelines regarding serodilution 
of plasma because of the amount of transfused/infused fluids 
administered.
________
UPDATE
Model CVX CVX-300 Excimer Laser, Recall #Z-934-9, which appeared 
in the June 2, 1999 Enforcement Report should read:  CODE  
Serial numbers: 1468 thru 1502, 79600  79601  79602  79603
79605  79606  79610 thru 79631, 79805, 79806, 79807, 79808.
DISTRIBUTION:  Nationwide, Argentina, Canada, 
Europe.
QUANTITY:  67 units were distributed.

RECALLS AND FIELD CORRECTIONS:  DEVICES -- CLASS III
________
UPDATE
Hemoglobin Reagent, Recall #Z-947-9 which appeared in the June 8, 
1999 Enforcement Report is a Class III recall.

END OF ENFORCEMENT REPORT FOR JUNE 16, 1999. 
####